118 related articles for article (PubMed ID: 4007353)
1. [Myocardial ischemia during exertion. Correlations between blood levels of thromboxane B2 and changes in coronary flow and resistance].
De Servi S; Vidale E; Mussini A; Cafiso A; Gavazzi A; Falcone C; Bramucci E; Angoli L; Ferrario M; Ghio S
G Ital Cardiol; 1985 Jan; 15(1):5-9. PubMed ID: 4007353
[TBL] [Abstract][Full Text] [Related]
2. [Effects of the cold pressor test and mental stress on coronary flow and resistance in patients with angina pectoris].
De Servi S; Ferrario M; Mussini A; Gavazzi A; Angoli L; Ghio S; Bramucci E; Montemartini C; Specchia G
G Ital Cardiol; 1984 May; 14(5):305-11. PubMed ID: 6468810
[TBL] [Abstract][Full Text] [Related]
3. Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease.
Hirsh PD; Hillis LD; Campbell WB; Firth BG; Willerson JT
N Engl J Med; 1981 Mar; 304(12):685-91. PubMed ID: 6894016
[TBL] [Abstract][Full Text] [Related]
4. Significance of thromboxane A2 in myocardial ischemia in patients with coronary artery disease.
Tada M; Kuzuya T; Inoue M; Kodama K; Fukushima M; Abe H
Adv Myocardiol; 1980; 2():397-405. PubMed ID: 7423053
[TBL] [Abstract][Full Text] [Related]
5. Role of thromboxanes in vasotonic versus vaso-occlusive angina.
Lewy RI
Arch Mal Coeur Vaiss; 1983 Feb; 76 Spec No():13-6. PubMed ID: 6407435
[TBL] [Abstract][Full Text] [Related]
6. Regulation of coronary blood flow during exercise.
Duncker DJ; Bache RJ
Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
[TBL] [Abstract][Full Text] [Related]
7. Thromboxane A2 in vasotonic angina pectoris: evidence from direct measurements and inhibitor trials.
Robertson RM; Robertson D; Roberts LJ; Maas RL; FitzGerald GA; Friesinger GC; Oates JA
N Engl J Med; 1981 Apr; 304(17):998-1003. PubMed ID: 7010173
[TBL] [Abstract][Full Text] [Related]
8. [Clinical estimation of the relation between coronary artery disease and regional myocardial blood flow by continuous thermodilution with the multithermistor catheter].
Mikuniya A; Fukuhara Y; Fujino Y; Yamanaka T; Sekiguchi H; Narita H; Koh M; Momose A; Oike Y; Onodera K
J Cardiogr; 1983 Jun; 13(2):291-300. PubMed ID: 6676378
[TBL] [Abstract][Full Text] [Related]
9. [Measurement of regional and global coronary sinus blood flow with the continuous thermodilution technique. II. Clinical studies in patients with coronary heart disease (author's transl)].
Kupper W; Bleifeld W
Z Kardiol; 1981 Feb; 70(2):116-23. PubMed ID: 7222905
[TBL] [Abstract][Full Text] [Related]
10. Transcoronary platelet thromboxane A2 formation without platelet trapping in patients with coronary stenosis-effect of sulphinpyrazone treatment.
Cortellaro M; Boschetti C; Antoniazzi V; Moreo G; Repetto S; Verna E; Boscarini M; Limido A; Binaghi G; Polli EE
Thromb Haemost; 1983 Dec; 50(4):857-9. PubMed ID: 6665767
[TBL] [Abstract][Full Text] [Related]
11. Clinical application of monitoring techniques: coronary sinus blood flow monitoring.
Specchia G; De Servi S; Poma E; Ghio S; Ferrario M; Angoli L; Ardissino D; Bramucci E; Mussini A
Can J Cardiol; 1986 Jul; Suppl A():170A-172A. PubMed ID: 3756582
[TBL] [Abstract][Full Text] [Related]
12. Coronary and systemic 6-ketoprostaglandin F1 alpha and thromboxane B2 during myocardial ischemia in dog.
Prosdocimi M; Finesso M; Gorio A; Languino LR; Del Maschio A; Castagnoli MN; De Gaetano G; Dejana E
Am J Physiol; 1985 Apr; 248(4 Pt 2):H493-9. PubMed ID: 3838623
[TBL] [Abstract][Full Text] [Related]
13. Dissociation of platelet activation and spontaneous myocardial ischemia in unstable angina.
Vejar M; Fragasso G; Hackett D; Lipkin DP; Maseri A; Born GV; Ciabattoni G; Patrono C
Thromb Haemost; 1990 Apr; 63(2):163-8. PubMed ID: 2363117
[TBL] [Abstract][Full Text] [Related]
14. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
[TBL] [Abstract][Full Text] [Related]
15. [Responses of plasma eicosanoids and hemodynamics to myocardial ischemia and the salutary effect of calcium entry blocker].
Takase B
Nihon Ika Daigaku Zasshi; 1990 Feb; 57(1):42-54. PubMed ID: 2329180
[TBL] [Abstract][Full Text] [Related]
16. [Myocardial microcirculation in humans--new approaches using MRI].
Wacker CM; Bauer WR
Herz; 2003 Mar; 28(2):74-81. PubMed ID: 12669220
[TBL] [Abstract][Full Text] [Related]
17. Thromboxane release in coronary artery disease: spontaneous versus pacing-induced angina.
Mehta J; Mehta P; Feldman RL; Horalek C
Am Heart J; 1984 Feb; 107(2):286-92. PubMed ID: 6695662
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic effects of the calcium channel blocker pranidipine on exercise-induced angina.
Nishinaka Y; Yokota M; Watanabe M; Sobue T; Iwase M; Ukai M; Ando A; Nagata K; Saito H
Int J Clin Pharmacol Ther; 1994 Oct; 32(10):542-9. PubMed ID: 7834162
[TBL] [Abstract][Full Text] [Related]
19. Thromboxane and prostacyclin changes during cardiopulmonary bypass with and without pulsatile flow.
Watkins WD; Peterson MB; Kong DL; Kono K; Buckley MJ; Levine FH; Philbin DM
J Thorac Cardiovasc Surg; 1982 Aug; 84(2):250-6. PubMed ID: 6980332
[TBL] [Abstract][Full Text] [Related]
20. Lipid peroxides, prostacyclin, and thromboxane A2 in runners during acute exercise.
Viinikka L; Vuori J; Ylikorkala O
Med Sci Sports Exerc; 1984 Jun; 16(3):275-7. PubMed ID: 6379367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]